# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-22-000135
Filing Date
2022-11-08
Accepted
2022-11-08 16:03:23
Documents
66
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lgnd-20220930.htm iXBRL | 10-Q | 1799126
2 | EX-10.1 | exhibit101-aremployeematte.htm | EX-10.1 | 253580
3 | EX-31.1 | lgnd_93022exhibit311.htm | EX-31.1 | 15151
4 | EX-31.2 | lgnd_93022exhibit312.htm | EX-31.2 | 15360
5 | EX-32.1 | lgnd_93022exhibit321.htm | EX-32.1 | 11280
11 |  | lgnd-20220930_g1.jpg | GRAPHIC | 51754
| Complete submission text file | 0000886163-22-000135.txt |  | 8961732

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lgnd-20220930.xsd | EX-101.SCH | 48275
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lgnd-20220930_cal.xml | EX-101.CAL | 93984
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lgnd-20220930_def.xml | EX-101.DEF | 261955
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lgnd-20220930_lab.xml | EX-101.LAB | 666845
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lgnd-20220930_pre.xml | EX-101.PRE | 424264
60 | EXTRACTED XBRL INSTANCE DOCUMENT | lgnd-20220930_htm.xml | XML | 1695370

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 221368793
SIC: 2834 Pharmaceutical Preparations